Zdrowie i gospodarka · 07/09/2022
FDA Corrects Notice on MAKENA Approval Withdrawal Hearing
The FDA is correcting a notice regarding a hearing on the withdrawal of approval for MAKENA, a drug application submitted by Covis Pharma Group/Covis Pharma GmbH, due to an incorrect publication deadline.